India’s Healthcare Business Daily
Search the archive
Key Coverage
Follow IndiaMedToday
Topic
1 article
The first ever fixed dose formulation in oncology to combine two monoclonal antibodies - Perjeta (pertuzumab) and Herceptin Roche Pharma…